Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by İrfan Nuhoglu
Increased Plasminogen Activator Inhibitor-1, Decreased Tissue Factor Pathway Inhibitor, and Unchanged Thrombin-Activatable Fibrinolysis Inhibitor Levels in Patients With Primary Hyperparathyroidism
European Journal of Endocrinology
Medicine
Endocrinology
Metabolism
Diabetes
Related publications
Thrombin and Plasmin Generation in Patients With Plasminogen or Plasminogen Activator Inhibitor Type 1 Deficiency
Haemophilia
Medicine
Genetics
Hematology
Plasma Thrombin-Activatable Fibrinolysis Inhibitor Levels Correlate With the Disease Activity of Ulcerative Colitis
Internal Medicine
Internal Medicine
Medicine
Thrombin-Activatable Fibrinolysis Inhibitor Polymorphisms and Cerebral Venous Thrombosis in Mexican Mestizo Patients
Clinical and Applied Thrombosis/Hemostasis
Medicine
Hematology
Thrombin-Activatable Fibrinolysis Inhibitor (TAFI) Deficiency Is Compatible With Murine Life
Journal of Clinical Investigation
Medicine
Changes in Plasma Levels of Tissue Plasminogen Activator and Plasminogen Activator Inhibitor-1 in Sepsis With Organ Failure.
Nihon Kyukyu Igakukai Zasshi
Biochemical Characterization of Bovine Plasma Thrombin-Activatable Fibrinolysis Inhibitor (TAFI)
Thrombin Activatable Fibrinolysis Inhibitor, a Potential Regulator of Vascular Inflammation
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Thrombin-Activatable Fibrinolysis Inhibitor Deficiency Attenuates Bleomycin-Induced Lung Fibrosis
American Journal of Pathology
Forensic Medicine
Pathology
Increased Plasma Plasminogen Activator Inhibitor-1 Levels Caused by Additional Aspirin Treatment
Thrombosis and Haemostasis
Hematology
